Stryker Corporation Recalls MOLLI 2 System Components Over Marker Dislodgement Risk
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Stryker Corporation is recalling 5,864 units of the MOLLI 2 System to update product labeling after reports of magnetized surgical tools dislodging markers during medical procedures.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Stryker Corporation has initiated a voluntary recall of the MOLLI 2 System due to a necessary update to the product's Instructions for Use (IFU). The recall was prompted by findings that magnetized surgical tools can dislodge markers while they are being used during target tissue removal procedures. The MOLLI Marker is designed to be placed in soft tissue to temporarily mark a surgical site for removal.
Which Products Are Affected
A total of 5,864 units are affected by this recall. The MOLLI 2 System components include:
- MOLLI Introducer (8cm, 14G) and MOLLI Marker: Catalog Number MM1000 (Pack of 10), UDI (GTIN) 00850024195028.
- MOLLI Introducer (12cm, 14G) and MOLLI Marker: Catalog Number MS-00009 (Pack of 10), UDI (GTIN) 00850024195134.
- MOLLI 2 Wand: Catalog Number MP2001, UDI (GTIN) 00850024195141.
- MOLLI OncoPen: Catalog Number MP2015A, UDI (GTIN) 00850024195219.
- MOLLI 2 Tablet: Catalog Number MT2001, UDI (GTIN) 00850024195158.
Distribution was worldwide, including nationwide across 47 U.S. states and the District of Columbia, as well as Canada, Singapore, Panama, Jamaica, and the Cayman Islands.
What You Should Do
Stryker Corporation initiated the recall by sending notification letters to affected customers starting January 21, 2026. Healthcare providers and facilities using the MOLLI 2 System should review the updated Instructions for Use (IFU) provided by the firm to ensure surgical tools do not inadvertently dislodge markers during procedures.
Why This Matters
This recall is significant because the unintended movement or dislodgement of a surgical marker during tissue removal could lead to inaccuracies during surgery or the failure to remove the intended target tissue. The FDA has classified this as a Class II recall.
Source
Recall information provided by the FDA under Recall Number Z-1427-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.